Search research articles
Contact Us
Filters
Showing results (161-170 of 299) with videos related to
Page
of 30
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare study
Jonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.
International Journal of Molecular Sciences
|
June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
Nicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia
Avadhut D Joshi, Ganapati V Hegde, John D Dickinson, et al.
American Journal of Hematology
|
April 11, 2012
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
Zdravko Mitrovic, Anamarija M Perry, Junji Suzumiya, et al.
Blood
|
January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
Jonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2008
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
Peter H Wiernik, Izidore S Lossos, Joseph M Tuscano, et al.
JCO Oncology Practice
|
September 30, 2020
Benchmarks for Academic Oncology Faculty
Lowell Anthony, George Atweh, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project
Massimo Federico, Thomas Rudiger, Monica Bellei, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 299) with videos related to
Sort By:
Page
of 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2009
Follicular lymphoma in the United States: first report of the national LymphoCare study
Jonathan W Friedberg, Michael D Taylor, James R Cerhan, et al.
International Journal of Molecular Sciences
|
June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
Nicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia
Avadhut D Joshi, Ganapati V Hegde, John D Dickinson, et al.
American Journal of Hematology
|
April 11, 2012
The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project
Zdravko Mitrovic, Anamarija M Perry, Junji Suzumiya, et al.
Blood
|
January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
Jonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 9, 2008
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
Peter H Wiernik, Izidore S Lossos, Joseph M Tuscano, et al.
JCO Oncology Practice
|
September 30, 2020
Benchmarks for Academic Oncology Faculty
Lowell Anthony, George Atweh, Ravi Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2012
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project
Massimo Federico, Thomas Rudiger, Monica Bellei, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Page
of 30